Forum on Drug Discovery, Development, and Translation 2016 Annual Report (2017) / Chapter Skim
Currently Skimming:
Forum Themes and Priorities
Forum Themes and Priorities
Pages 16-21
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 16... ...
The Forum offers a venue to discuss effective collaboration in the drug discovery and develop ment enterprise and also hosts discussions that could help chart a course through the turbulent forces of disruptive innovation in the drug discovery and development "ecosystem." February 12 May 12 August 21 Workshop: Characterizing and Workshop: Characterizing and Action Collaborative Meeting #2: Communicating Uncertainty in the Communicating Uncertainty in the Developing a National Accreditation System Assessment of Benefits and Risks of Assessment of Benefits and Risks of to Improve Clinical Trial Performance Pharmaceutical Products (Day 1) Pharmaceutical Products (Day 2)
|
From page 17... ...
Clinical Trials and Clinical Product Development Clinical research is the critical link between bench and bedside in developing new therapeutics. Significant infrastructural, cultural, and regulatory impediments challenge efforts to integrate clinical trials into the health care delivery system.
|
From page 18... ...
The Forum will also host an initiative that will address needs for a workforce across the transla tional science lifecycle. October 20 March 22 Workshop: Advancing the Discipline of February 3 Workshop: Deriving Regulatory Science for Medical Product Action Collaborative Drug Discovery Value Development: An Update on Progress Meeting #1: IT/Technical from Large-Scale and a Forward-Looking Agenda Infrastructure for Sharing Genetic Bioresources 2016 June 23–24 October 21 March 23 Forum Meeting #31 Forum Meeting #32 Forum Meeting #33
|
From page 19... ...
Forum Themes and Priorities OVERVIEW The Forum fosters dialogue and collaboration to illuminate and act on potentially breakthrough ideas and visionary approaches to the biomedical innovation system of the future. THEMATIC PRIORITIES ACTIVITIES Innovation & the Enterprise Workshops Science Across the Lifecycle Action Collaboratives Clinical Trials & Product Forum Meetings Development Infrastructure & Workforce ACTIVITIES THEMATIC PRODUCTS PRIORITIES Workshop Proceedings PARTNERS Discussion Papers & Commentaries PRODUCTS Peer-reviewed Journal Articles STR ATEGIES STRATEGIES Facilitate visibility & PARTNERS continuous discussion Foster collaboration Biopharmaceutical Companies Explore innovative & transformative approaches Academic Researchers Educate & elevate understanding of issues Patient & Disease Advocacy Groups Clarify & expand areas of agreement Foundations, Associations, & Consortia Set the stage for policy action Federal Research & Regulatory Agencies July 14 October 19 December 12–13 Action Collaborative Meeting Workshop: Real-World Workshop: The Drug #1: Data Sharing Principles for Evidence Generation and Development Paradigm Nonprofit Clinical Trial Funders Evaluation of Therapeutics in Oncology July 19–20 October 18 Forum Meeting #34 Forum Meeting #35
|
From page 20... ...
The workshop, co-sponsored by the Burroughs Wellcome Fund, also held panels that explored key needs for strengthening the discipline of regulatory science, including considering what are the core components of regulatory science infrastructure to foster innovation in medical product development. To focus the workshop discussions, the planning committee adopted the theme of innovation in regulatory science through integration of information.
|
From page 21... ...
Critics cite the need for the industry to produce more and better products and affordably innovate if it hopes to survive. To further assess the challenges and reveal potential opportunities, participants of an Action Collaborative convened under the auspices of the Forum engaged thought leaders and key stakeholders within the biomedical research ecosystem, soliciting diverse viewpoints to gain insight into their unique perspectives on the state of the pharmaceutical and biomedical research industries, what could or should change, how those changes might occur, and, generally, what the future might hold.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.